Market research
UDG.LSE UDG Healthcare plc
LSE GBP Healthcare
Latest close
As of 29 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3B
- P/E ratio
- 42.48
- Analyst target
- 10.26
- Dividend yield
- 1.2%
- Beta
- 0.65
Profile
Instrument facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- IE0033024807
- Market cap
- 3B
- P/E ratio
- 42.48
- Analyst target
- 10.26
- Dividend yield
- 1.2%
- Beta
- 0.65
About
About UDG Healthcare plc
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is headquartered in Dublin, the Republic of Ireland. As of August 16, 2021, UDG Healthcare plc was taken private.
Research context
UDG Healthcare plc appears in PyInvesting’s London Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the UDG.LSE discussion.
5 years, 6 months ago
UDG Healthcare plc is currently in a long term uptrend where the price is trading 27.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
UDG Healthcare plc's total revenue sank by 0.0% to $321M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $17M since the same quarter in the previous year.
Finally, its free cash flow grew by 116.9% to $61M since the same quarter in the previous year.
Based on the above factors, UDG Healthcare plc gets an overall score of 3/5.